Die Benzamide Tiaprid, Sulpirid und Amisulprid in der Therapie des Tourette-Syndroms

[1]  J. Jankovic,et al.  Emerging drugs in Tourette syndrome , 2005, Expert opinion on emerging drugs.

[2]  C. Winter,et al.  Tourette syndrome: Efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride , 2004, Movement Disorders.

[3]  E. Rüther,et al.  Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system. , 2004, Pharmacopsychiatry.

[4]  G. Kaprinis,et al.  Successful treatment of Tourette's disorder with amisulpride , 2004, The Annals of pharmacotherapy.

[5]  S. Leurgans,et al.  Objective assessments of longitudinal outcome in Gilles de la Tourette’s syndrome , 2003, Neurology.

[6]  K. Müller-Vahl,et al.  The treatment of Tourette’s syndrome: current opinions , 2002, Expert opinion on pharmacotherapy.

[7]  John E. Cooper,et al.  Diagnostic and Statistical Manual of Mental Disorders (4th edn, text revision) (DSM-IV-TR) , 2001 .

[8]  H. Singer.  Current issues in Tourette syndrome , 2000, Movement disorders : official journal of the Movement Disorder Society.

[9]  Paul Sandor,et al.  An international perspective on Tourette syndrome: selected findings from 3500 individuals in 22 countries , 2000, Developmental medicine and child neurology.

[10]  M. Robertson,et al.  Tourette syndrome, associated conditions and the complexities of treatment. , 2000, Brain : a journal of neurology.

[11]  Lionel Traverse,et al.  ‘Prevalence of Tourette syndrome in a mainstream school population’ , 1998, Developmental medicine and child neurology.

[12]  M. Robertson,et al.  The prevalence of Tourette syndrome in a mainstream school population , 1998, Developmental medicine and child neurology.

[13]  M. Trimble,et al.  Fluvoxamine and sulpiride in comorbid obsessive–compulsive disorder and gilles de la tourette syndrome , 1993 .

[14]  A. Lees,et al.  Management of Gilles de la Tourette syndrome using sulpiride. , 1990, Clinical neuropharmacology.

[15]  J. Daléry,et al.  [Treatment of Gilles de la Tourette's disease with amisulpride]. , 1990, Presse medicale.

[16]  H. Klepel,et al.  [Treatment of extrapyramidal hyperkineses in childhood with tiapride]. , 1988, Psychiatrie, Neurologie, und medizinische Psychologie.

[17]  J. Millichap.  Tourette's Syndrome , 1988 .

[18]  A. Lipcsey.  [Gilles de la Tourette's disease]. , 1983, La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris.

[19]  Sara Romero,et al.  [Clinical trial of tiapride in patients with dyskinesia (author's transl)]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

[20]  E. Caine,et al.  The trial use of clozapine for abnormal involuntary movement disorders. , 1979, The American journal of psychiatry.

[21]  G. Tourette,et al.  Etude d′une affection nerveuse caracterisee par de l′incoordination motorice accompagnee d′echolalie et de coprolalie(Archives de Neurologie(Paris),9〜42,158〜200,1885) , 1978 .

[22]  M. Yvonneau,et al.  [Apropos of a case of Gilles de la Tourette's disease blocked by sulpiride. Psycho-biological study]. , 1970, L'Encephale.

[23]  A. Rothenberger,et al.  Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride , 2004, European archives of psychiatry and neurological sciences.

[24]  金生由紀子.  Gilles de la Tourette : Etude sur une affection nerveuse caracterisee par de l'incoordination motorice accompagnee, d'echolalie et de coprolalie , 2003 .

[25]  H. Singer,et al.  Neurochemistry and synaptic neurotransmission in Tourette syndrome. , 2001, Advances in neurology.

[26]  B. Peterson,et al.  The treatment of Tourette's syndrome: multimodal, developmental intervention. , 1998, The Journal of clinical psychiatry.

[27]  P. Nádvorník,et al.  [Gilles de la Tourette's disease]. , 1972, Ceskoslovenska neurologie.